title: [Maastricht consensus-4 (2011). Main provisions and comments].
abstract: The author reviews the main articles and statements of the newly adopted Maastricht Consensus-4 (2011) on diagnostics and treatment of gastroduodenal diseases associated with H. pylori infection. Each statement is commented taking account of the author's experience and results of Russian and foreign researchers obtained by methods and techniques of evidence-based medicine. Corrected recommendations for diagnostics, therapeutic indications, and strategy of management of H. pylori-dependent diseases are proposed.
authors.forename: Ia S
authors.initials: IaS
authors.lastname: Tsimmerman
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003245:Consensus Statements as Topic; D003938:Diagnostic Techniques, Digestive System; D019468:Disease Management; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000379:methods; D019317:Evidence-Based Medicine; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D016481:Helicobacter Infections / Q000175:diagnosis / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D016480:Helicobacter pylori / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D011619:Psychotropic Drugs / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D011619:Psychotropic Drugs